Solid tumour diagnosis through large gene panel testing

On 14 July 2022 the North Thames Genomic Medicine Service (GMS) held an event showcasing how genomic medicine is transforming healthcare in our region.

Mike Hubank, Scientific Director at North Thames GLH and Head of Clinical Genomics (Research) at The Royal Marsden NHS Foundation Trust, explains how solid tumour diagnosis through large gene panel testing is helping to improve genetic and genomic diagnosis of cancer.